Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries

Lancet

Volumn 357, Issue 9261, 2001, Pages 995-1001

  Kotseva, K ^b   Wood, D ^a   De Backer, G ^b   De Bacquer, D ^b   Pyorala K ^b   Keil, U ^b   Sans, S ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; EUROPE; FEMALE; HEART INFARCTION PREVENTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035978089     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04235-5     Document Type: Article

References (19)

1. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
2. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
3. EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease, principal results
4. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)
5. Lifestyle and risk factor managementand use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II
6. Interval estimation for the difference between independent proportions: Comparison of eleven methods
7. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy
8. Impact of smoking cessation and smoking interventions in patients with coronary heart disease
9. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service Report
10. Overweight and obesity: A major challenge for coronary heart disease secondary prevention in clinical practice in Europe
11. Exercise-based rehabilitation for coronary heart disease
12. Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe: Findings from EUROASPIRE study
13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
14. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
15. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
16. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
17. La prevención secundaria del infarto de miocardio en España: Estudio PREVESE
18. The impact of landmark clinical trials on secondary prevention of acute myocardial infarction (AMI) in Spain: PREVESE 98 study
19. After 4S, CARE and LIPID: Is evidence-based medicine being practised?